Corvus Pharmaceuticals, Inc.
Clinical trials sponsored by Corvus Pharmaceuticals, Inc., explained in plain language.
-
New pill trial aims to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing whether a new oral medication called soquelitinib can safely reduce the rash and itch of moderate to severe eczema (atopic dermatitis). About 200 adults will take either the real pill or a placebo (a dummy pill with no medicine) daily for 12 weeks. Doctors w…
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pill challenges standard care for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing an experimental oral drug called soquelitinib against standard chemotherapy options for adults with specific aggressive T-cell lymphomas that have returned or not responded to prior treatment. About 150 participants will be randomly assigned to receive eithe…
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC